2297 Stock Overview
Operates as a vascular interventional surgical robotics company in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Rainmed Medical Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.16 |
| 52 Week High | HK$0.70 |
| 52 Week Low | HK$0.13 |
| Beta | 1.28 |
| 1 Month Change | -11.35% |
| 3 Month Change | -22.64% |
| 1 Year Change | -66.53% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -96.89% |
Recent News & Updates
Recent updates
Shareholder Returns
| 2297 | HK Medical Equipment | HK Market | |
|---|---|---|---|
| 7D | 0% | 1.0% | 0.8% |
| 1Y | -66.5% | -26.9% | 21.1% |
Return vs Industry: 2297 underperformed the Hong Kong Medical Equipment industry which returned -26.9% over the past year.
Return vs Market: 2297 underperformed the Hong Kong Market which returned 21.1% over the past year.
Price Volatility
| 2297 volatility | |
|---|---|
| 2297 Average Weekly Movement | 17.1% |
| Medical Equipment Industry Average Movement | 9.0% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in HK Market | 18.6% |
| 10% least volatile stocks in HK Market | 4.1% |
Stable Share Price: 2297's share price has been volatile over the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2297's weekly volatility (17%) has been stable over the past year, but is still higher than 75% of Hong Kong stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 266 | Yunfei Huo | rainmed.com |
Rainmed Medical Limited operates as a vascular interventional surgical robotics company in China and internationally. It engages in the research and development, manufacturing, and commercialization of medical instrument related to coronary angiography-derived fractional flow reserve (caFFR) systems and coronary angiography-derived index of microvascular resistance (caIMR) systems. The company offers caFFR systems comprising FlashAngio caFFR System and FlashPressure caFFR pressure transducer for a less-invasive physiological assessment of coronary artery ischemia severity based on coronary angiography images; and caIMR System, including FlashAngio caIMR System and FlashPressure caIMR pressure transducer, which is a less-invasive index of microcirculatory resistance measurement product for the treatment of microcirculatory lesions.
Rainmed Medical Limited Fundamentals Summary
| 2297 fundamental statistics | |
|---|---|
| Market cap | HK$190.35m |
| Earnings (TTM) | -HK$117.08m |
| Revenue (TTM) | HK$52.92m |
3.6x
P/S Ratio-1.6x
P/E RatioIs 2297 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2297 income statement (TTM) | |
|---|---|
| Revenue | CN¥49.71m |
| Cost of Revenue | CN¥19.76m |
| Gross Profit | CN¥29.96m |
| Other Expenses | CN¥139.95m |
| Earnings | -CN¥110.00m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.094 |
| Gross Margin | 60.26% |
| Net Profit Margin | -221.26% |
| Debt/Equity Ratio | 5.3% |
How did 2297 perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/24 12:07 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Rainmed Medical Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|